Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+48Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Prostate Neoplasm+12Malignant Mesothelioma+8Malignant Kidney Neoplasm+4Malignant Liver Neoplasm+4Malignant Testicular Neoplasm+4Malignant Lung Neoplasm0Malignant Penile Neoplasm0Malignant Thyroid Gland Neopl…0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+48100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21514
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
88
activityPercentile
40

ranking row 2602521

2=Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11888
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2602523

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2960
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2602522

4=Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5312
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2602524

5=Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12314
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2602525

5=Malignant Pancreatic Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
22919
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
92
activityPercentile
76

ranking row 2602526

5=Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
648
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2602527

8=Malignant Prostate Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30486
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2602528

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2024
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2602529

10=Malignant Kidney Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9036
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56

ranking row 2602530

10=Malignant Liver Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18244
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2602531

10=Malignant Testicular Neoplasm+464Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
425
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
8
activityPercentile
4

ranking row 2602532

13=Malignant Lung Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
78694
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2602533

13=Malignant Penile Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
352
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
4
activityPercentile
4

ranking row 2602535

13=Malignant Thyroid Gland Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
889
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2602534

16=Malignant Rectal Neoplasm-440Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6283
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
48
activityPercentile
52

ranking row 2602536

17=Leukemia-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13618
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2602537

17=Malignant Anal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
437
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
12
activityPercentile
20

ranking row 2602540

17=Malignant Central Nervous System Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9389
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
64
activityPercentile
72

ranking row 2602538

17=Malignant Hypopharyngeal Neoplasm-836Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
333
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
8

ranking row 2602539

21=Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
569
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
24
activityPercentile
36

ranking row 2602541

21=Malignant Gastric Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6680
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
52
activityPercentile
64

ranking row 2602542

21=Multiple Myeloma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6852
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56
activityPercentile
68

ranking row 2602543

24=Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11647
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2602544

25=Malignant Nasopharyngeal Neoplasm-284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
501
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16
activityPercentile
44

ranking row 2602545

26=Malignant Breast Neoplasm-760Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
510
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
20
activityPercentile
96

ranking row 2602546

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash b8fddcf9732c9f29f4ff9b6a